Literature DB >> 2960276

Decreased monocyte production of interleukin-1 and impaired lymphocyte proliferation in atopic dermatitis.

L Räsänen1, M Lehto, T Reunala, C Jansen, P Leinikki.   

Abstract

We studied lymphocyte proliferation and subsets in ten atopic dermatitis (AD) patients and ten healthy controls. In addition, monocyte production of interleukin 1 (IL-1) was investigated. Mean numbers of total T cells, T-cells subsets, and B cells did not significantly differ between AD patients and controls even though the patients had slightly decreased amounts of suppressor T lymphocytes. Proliferative responses of AD patients to purified protein derivative of tuberculin (PPD), concanavalin A (ConA), or allogeneic cells did not significantly differ from those of healthy controls at optimal stimulant concentrations. In contrast, at suboptimal concentrations, AD patients showed a diminished response to all of these stimulants. Monocytes from AD patients elaborated clearly less IL-1 than those from healthy controls.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960276     DOI: 10.1007/bf00417317

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  17 in total

1.  Immunoglobulin E in dermatoses. Levels in atopic dermatitis and urticaria.

Authors:  L Juhlin; G O Johansson; H Bennich; C Högman; N Thyresson
Journal:  Arch Dermatol       Date:  1969-07

2.  Lymphocyte transformation tests and subpopulations of lymphocytes in a population-based material of atopic dermatitis in twins.

Authors:  F Schultz Larsen; N Grunnet
Journal:  Scand J Immunol       Date:  1985-04       Impact factor: 3.487

3.  Quantitative analysis of T-lymphocyte subsets in atopic eczema, using monoclonal antibodies and flow cytofluorimetry.

Authors:  C B Zachary; D M MacDonald
Journal:  Br J Dermatol       Date:  1983-04       Impact factor: 9.302

4.  Cellular basis of defective cell-mediated lympholysis in atopic dermatitis.

Authors:  D Y Leung; N Wood; D Dubey; A R Rhodes; R S Geha
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

Review 5.  Newer concepts of atopic dermatitis.

Authors:  J M Hanifin; W C Lobitz
Journal:  Arch Dermatol       Date:  1977-05

6.  In vitro immunological studies in atopic and contact dermatitis.

Authors:  J Bousquet; M Andary; J Clot; D J Guilhou; J Meynadier
Journal:  Ann Allergy       Date:  1978-09

7.  Enumeration of T cell subsets in atopic dermatitis using monoclonal antibodies.

Authors:  D Y Leung; A R Rhodes; R S Geha
Journal:  J Allergy Clin Immunol       Date:  1981-06       Impact factor: 10.793

8.  Regulation of human IgE synthesis.

Authors:  D Y Leung; R S Geha
Journal:  J Invest Dermatol       Date:  1985-07       Impact factor: 8.551

9.  Immunodeficiencies in severe atopic dermatitis. Depressed chemotaxis and lymphocyte transformation.

Authors:  J L Rogge; J M Hanifin
Journal:  Arch Dermatol       Date:  1976-10

10.  Depression of cell-mediated immunity in atopic eczema.

Authors:  S J McGeady; R H Buckley
Journal:  J Allergy Clin Immunol       Date:  1975-11       Impact factor: 10.793

View more
  3 in total

1.  Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities.

Authors:  U Reinhold; W Wehrmann; S Kukel; H W Kreysel
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

2.  Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis.

Authors:  T Jakob; B N Huspith; Y E Latchman; R Rycroft; J Brostoff
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

3.  Elimination of IgE regulatory rat CD8+ T cells in vivo differentially modulates interleukin-4 and interferon-gamma but not interleukin-2 production by splenic T cells.

Authors:  D Diaz-Sanchez; A Noble; D Z Staynov; T H Lee; D M Kemeny
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.